France’s Bionyra Pharma launches with €143 million Series A to advance inflammatory disease biologics
Bionyra Pharma, a Paris and Boston-based clinical-stage biopharma company developing next-generation biologics for immune-mediated inflammatory diseases, today announced the company’s...
